FDA Approved IDE Clinical Study

Regentis Biomaterials Performs the First Cases in GelrinC Pivotal Study

PRINCETON, New Jersey and OR AKIVA, Israel, November 28, 2017 /PRNewswire/ — Regentis Biomaterials announced today the start of its Phase III pivotal clinical trial…